13RS HB79
LRC Seal

HB79

13RS

WWW Version

The hyperlink to a bill draft that precedes a summary contains the most recent version (Introduced/GA/Enacted) of the bill. If the session has ended, the hyperlink contains the latest version of the bill at the time of sine die adjournment. Note that the summary pertains to the bill as introduced, which is often different from the most recent version.


HB 79/FN (BR 288) - T. Burch, K. Flood

     AN ACT relating to the prescription of naloxone.
     Create a new section of KRS Chapter 217.005 to 217.215 to exempt licensed health-care providers from disciplinary action for prescribing or dispensing naloxone for an opioid overdose.

HB 79 - AMENDMENTS


     HCS/FN - Create a new section of KRS Chapter 217.005 to 217.215 to exempt licensed health-care providers from disciplinary action for prescribing or dispensing naloxone for an opioid overdose; create another new section of KRS 217.005 to KRS 217.215 to allow a prescription for naloxone to be written with an authorization for a third party individual to administer the drug; provide that the third party individual who administers naloxone in good faith is immune from civil liability.
     HFA (1, T. Burch) - Retain original provisions and clarify that a third party individual who administers naloxone in good faith is immune from criminal and civil liability.
     HFA (2/P, A. Wuchner) - Retain original provisions; create a new section of KRS 218A to allow a practitioner to prohibit substitution when the practitioner determines that substitution is not in the best interest of the patient; exempt drugs prescribed or dispensed for patients in a nursing home or hospice care setting; prohibit substitution or interchange of those drugs without the pharmacy verifying that the substitute provides substantially similar tamper-resistance properties as determined by the board or without obtaining written consent of the prescriber; require the Kentucky Board of Pharmacy to publish and, in some cases, determine qualifying drugs for a list of opioid analgesics that incorporate tamper-resistance technologies; exempt from compliance pharmacists in hospital-based pharmacies filling prescriptions for inpatient care; name Section 3 of this bill the STOPP in Kentucky Act of 2013; and to establish that the provisions of Section 3 of this bill will expire upon the adoption of national standards related to tamper-resistant technology for drugs by the United States Food and Drug Administration.
     HFA (3/P, A. Wuchner) - Retain original provisions; create a new section of KRS 218A to allow a practitioner to prohibit substitution when the practitioner determines that substitution is not in the best interest of the patient; exempt drugs prescribed or dispensed for patients in a nursing home or hospice care setting; prohibit substitution or interchange of those drugs without the pharmacy verifying that the substitute provides substantially similar tamper-resistance properties as determined by the board or without obtaining written consent of the prescriber; require the Kentucky Board of Pharmacy to publish and, in some cases, determine qualifying drugs for a list of opioid analgesics that incorporate tamper-resistance technologies; exempt from compliance pharmacists in hospital-based pharmacies filling prescriptions for inpatient care; name Section 3 of this bill the STOPP in Kentucky Act of 2013; establish that the provisions of Section 3 of this bill will expire upon the adoption of national standards related to tamper-resistant technology for drugs by the United States Food and Drug Administration.
     HFA (4/Title, A. Wuchner) - Make title amendment.
     HFA (5, T. Moore) - Amend KRS 413.140, and create a new section of KRS Chapter 413 to create a special 20-year statute of limitations for actions against abortion providers.
     HFA (6, T. Moore) - Amend KRS 413.140, and create a new section of KRS Chapter 413 to create a special 20-year statute of limitations for actions against abortion providers.
     HFA (7/Title, T. Moore) - Make title amendment.

     Jan 8-introduced in House
     Jan 9-to Health & Welfare (H)
     Feb 6-posted in committee
     Feb 25-taken from Health & Welfare (H); 1st reading; returned to Health & Welfare (H)
     Feb 26-reported favorably, 2nd reading, to Rules with Committee Substitute ; floor amendments (1) and (3) filed to Committee Substitute, floor amendments (2) and (4-title) filed
     Feb 27-posted for passage in the Regular Orders of the Day for Thursday, February 28, 2013; floor amendment (6) filed to Committee Substitute, floor amendments (5) and (7-title) filed
     Mar 4-taken from the Regular Orders of the Day; recommitted to Health & Welfare (H)


Legislature Home Page | Record Front Page